Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eduard Grebe

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Plos Neglected Tropical Diseases|March 17, 2023
Standardized evaluation of Zika nucleic acid tests used in clinical settings and blood screeningMars Stone, Sonia Bakkour, Eduard Grebe, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 16, 2017
Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay PlatformsEduard Grebe, Alex Welte, Jake Hall, et al.
AIDS Research and Human Retroviruses|April 3, 2019
Evaluation of the Performance of Three Biomarker Assays for Recent HIV Infection Using a Well-Characterized HIV-1 Subtype C Incidence CohortElizabeth Gonese, Peter H Kilmarx, Cari van Schalkwyk, et al.
Microbiology Spectrum|April 10, 2026
Longitudinal evaluation of HIV-1 LAg incidence assay and proficiency panel stability for external quality assuranceClara Di Germanio, Wes Rountree, Eduard Grebe, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 11, 2016
Performance of the Bio-Rad Geenius HIV1/2 Supplemental Assay in Detecting "Recent" HIV Infection and Calculating Population IncidenceSheila M Keating, Reshma Kassanjee, Mila Lebedeva, et al.
Microbiology Spectrum|June 22, 2023
Evaluation of Ortho VITROS and Roche Elecsys S and NC Immunoassays for SARS-CoV-2 Serosurveillance ApplicationsHasan Sulaeman, Eduard Grebe, Honey Dave, et al.
Transfusion|February 8, 2021
Selecting COVID-19 convalescent plasma for neutralizing antibody potency using a high-capacity SARS-CoV-2 antibody assayErin Goodhue Meyer, Graham Simmons, Eduard Grebe, et al.
Transfusion|August 30, 2020
Recently acquired infection among HIV-seropositive donors in the US from 2010-2018Claire Quiner, Roberta Bruhn, Eduard Grebe, et al.
Transfusion|April 14, 2025
HIV incidence in US first-time blood donors during 12 and 3 month deferral policy periods between 2015 and 2023 before implementation of individual donor assessmentEduard Grebe, Clara Di Germanio, Edward P Notari, et al.
Transfusion|June 14, 2021
SARS-CoV-2 antibody persistence in COVID-19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillanceClara Di Germanio, Graham Simmons, Kathleen Kelly, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Plos Neglected Tropical Diseases|March 17, 2023
Standardized evaluation of Zika nucleic acid tests used in clinical settings and blood screeningMars Stone, Sonia Bakkour, Eduard Grebe, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 16, 2017
Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay PlatformsEduard Grebe, Alex Welte, Jake Hall, et al.
AIDS Research and Human Retroviruses|April 3, 2019
Evaluation of the Performance of Three Biomarker Assays for Recent HIV Infection Using a Well-Characterized HIV-1 Subtype C Incidence CohortElizabeth Gonese, Peter H Kilmarx, Cari van Schalkwyk, et al.
Microbiology Spectrum|April 10, 2026
Longitudinal evaluation of HIV-1 LAg incidence assay and proficiency panel stability for external quality assuranceClara Di Germanio, Wes Rountree, Eduard Grebe, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 11, 2016
Performance of the Bio-Rad Geenius HIV1/2 Supplemental Assay in Detecting "Recent" HIV Infection and Calculating Population IncidenceSheila M Keating, Reshma Kassanjee, Mila Lebedeva, et al.
Microbiology Spectrum|June 22, 2023
Evaluation of Ortho VITROS and Roche Elecsys S and NC Immunoassays for SARS-CoV-2 Serosurveillance ApplicationsHasan Sulaeman, Eduard Grebe, Honey Dave, et al.
Transfusion|February 8, 2021
Selecting COVID-19 convalescent plasma for neutralizing antibody potency using a high-capacity SARS-CoV-2 antibody assayErin Goodhue Meyer, Graham Simmons, Eduard Grebe, et al.
Transfusion|August 30, 2020
Recently acquired infection among HIV-seropositive donors in the US from 2010-2018Claire Quiner, Roberta Bruhn, Eduard Grebe, et al.
Transfusion|April 14, 2025
HIV incidence in US first-time blood donors during 12 and 3 month deferral policy periods between 2015 and 2023 before implementation of individual donor assessmentEduard Grebe, Clara Di Germanio, Edward P Notari, et al.
Transfusion|June 14, 2021
SARS-CoV-2 antibody persistence in COVID-19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillanceClara Di Germanio, Graham Simmons, Kathleen Kelly, et al.
Pageof 8